1887

Abstract

Cytomegalovirus (CMV) infection in the period of temporary immunodeficiency after haematoablative treatment and bone marrow transplantation (BMT) is associated with a risk of graft failure and multiple-organ CMV disease. The efficacy of immune system reconstitution is decisive for the prevention of CMV pathogenesis after BMT. Previous data in murine model systems have documented a redundancy in the immune effector mechanisms controlling CMV. CD8 T cells proved to be relevant but not irreplaceable as antiviral effectors. Specifically, in a state of long-term depletion of the CD8 T-cell subset, CD4 T cells were educed to become deputy effectors controlling CMV by a mechanism involving antiviral cytokines. It is of medical importance to know whether one can trust in this 'flexible defence’ in all clinical settings. It is demonstrated here that reconstitution of CD8 T cells is crucial for the prevention of fatal multiple- organ CMV disease under the specific conditions of BMT.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-79-9-2099
1998-09-01
2022-01-29
Loading full text...

Full text loading...

/deliver/fulltext/jgv/79/9/9747717.html?itemId=/content/journal/jgv/10.1099/0022-1317-79-9-2099&mimeType=html&fmt=ahah

References

  1. Balthesen M., Messerle M., Reddehase M. J. 1993; Lungs are a major organ site of cytomegalovirus latency and recurrence. Journal of Virology 67:5360–5366
    [Google Scholar]
  2. Cobbold S. P., Jayasuriya A., Nash A., Prospero T. D., Waldmann H. 1984; Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature 312:548–550
    [Google Scholar]
  3. Dobonici M., Podlech J., Steffens H. -P., Maiberger S., Reddehase M. J. 1998; Evidence against a key role for transforming growth factor- p1 in cytomegalovirus-induced bone marrow aplasia. Journal of General Virology 79:867–876
    [Google Scholar]
  4. Ebeling A., Keil G. M., Knust E., Koszinowski U. H. 1983; Molecular cloning and physical mapping of murine cytomegalovirus DNA. Journal of Virology 47:421–433
    [Google Scholar]
  5. Einsele H., Hebart H., Bokemeyer C., Kanz L., Jahn G., Müller C. A. 1998; Cytomegalovirus infection following hematopoietic stem cell transplantation. Monographs in Virology 21:106–118
    [Google Scholar]
  6. Holt P. G., Degebrodt A., Venaille T., O’Leary C., Krska K., Flexman J., Farrell H., Shellam G., Young P., Penhale J., Robertson T., Papadimitrio J. M. 1985; Preparation of interstitial lung cells by enzymatic digestion of tissue slices: preliminary characterization by morphology and performance in functional assays. Immunology 54:139–147
    [Google Scholar]
  7. Jonjić S., Mütter W., Weiland F., Reddehase M. J., Koszinowski U. H. 1989; Site-restricted persistent cytomegalovirus infection after selective long-term depletion of CD4+ T lymphocytes. Journal of Experimental Medicine 169:1199–1212
    [Google Scholar]
  8. Jonjić S., Pavić I., Lučin P., Rukavina D., Koszinowski U. H. 1990; Efficacious control of cytomegalovirus infection after long-term depletion of CD8+ T lymphocytes. Journal of Virology 64:5457–5464
    [Google Scholar]
  9. Jonjić S., Pavić I., Polic B., Crnković I., Lučin P., Koszinowski U. H. 1994; Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus. Journal of Experimental Medicine 179:1713–1717
    [Google Scholar]
  10. Kesari S., Lasner T. M., Balsara K. R., Randazzo B. P., Lee V. M. -Y., Trojanowski J. Q., Fraser N. W. 1998; A neuroattenuated ICP34.5- deficient herpes simplex virus type 1 replicates in ependymal cells of the murine central nervous system. Journal of General Virology 79:525–536
    [Google Scholar]
  11. Koszinowski U. H., Reddehase M. J., Jonjić S. 1993; The role of T- lymphocyte subsets in the control of cytomegalovirus infection. In Viruses and the Cellular Immune Response pp 429–445 Thomas D. B. Edited by New York: Marcel Dekker;
    [Google Scholar]
  12. Lathbury L. J., Allan J. E., Shellam G. R., Scalzo A. A. 1996; Effect of host genotype in determining the relative roles of natural killer cells and T cells in mediating protection against murine cytomegalovirus infection. Journal of General Virology 77:2605–2613
    [Google Scholar]
  13. Lučin P., Jonjić S., Messerle M., Polić B., Hengel H., Koszinowski U. H. 1994; Late phase inhibition of murine cytomegalovirus replication by synergistic action of interferon-gamma and tumour necrosis factor. Journal of General Virology 75:101–110
    [Google Scholar]
  14. Mayer A., Podlech J., Kurz S., Steffens H. -P., Maiberger S., Thalmeier K., Angele P., Dreher L., Reddehase M. J. 1997; Bone marrow failure by cytomegalovirus is associated with an in vivo deficiency in the expression of essential stromal hemopoietin genes. Journal of Virology 71:4589–4598
    [Google Scholar]
  15. Mutter W., Reddehase M. J., Busch F. W., Bühring H. -J., Koszi-nowski U. H. 1988; Failure in generating hematopoietic stem cells is the primary cause of death from cytomegalovirus disease in the immunocompromised host. The Journal of Experimental Medicine 167:1645–1658
    [Google Scholar]
  16. Pavić I., Polić B., Crnković I., Lučin P., Jonjić S., Koszinowski U. H. 1993; Participation of endogenous tumour necrosis factor a in host resistance to cytomegalovirus infection. Journal of General Virology 74:2215–2223
    [Google Scholar]
  17. Polić B., Jonjić S., Pavić I., Crnković I., Zorica I., Hengel H., Lučin P., Koszinowski U. H. 1996; Lack of MHC class I complex expression has no effect on spread and control of cytomegalovirus infection in vivo . Journal of General Virology 77:217–225
    [Google Scholar]
  18. Rawlinson W. D., Farrell H. E., Barrell B. G. 1996; Analysis of the complete DNA sequence of murine cytomegalovirus. Journal of Virology 70:8833–8849
    [Google Scholar]
  19. Reddehase M. J., Weiland F., Münch K., Jonjić S., Lüske A., Koszinowski U. H. 1985; Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs. Journal of Virology 55:264–273
    [Google Scholar]
  20. Reddehase M. J., Mutter W., Koszinowski U. H. 1987a; In vivo application of recombinant interleukin 2 in the immunotherapy of established cytomegalovirus infection. Journal of Experimental Medicine 165:650–656
    [Google Scholar]
  21. Reddehase M. J., Mutter W., Münch K., Bühring H. -J., Koszinowski U. H. 1987b; CD8-positive T lymphocytes specific for urine cytomegalovirus immediate-early antigens mediate protective immunity. Journal of Virology 67:3102–3108
    [Google Scholar]
  22. Reddehase M. J., Jonjić S., Weiland F., Mutter W., Koszinowski U. H. 1988; Adoptive immunotherapy of murine cytomegalovirus adrenalitis in the immunocompromised host : CD4-helper-independent antiviral function of CD8-positive memory T lymphocytes derived from latently infected donors. Journal of Virology 62:1061–1065
    [Google Scholar]
  23. Reusser P., Riddell S. R., Meyers J. D., Greenberg P. D. 1991; Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. Blood 78:1373–1380
    [Google Scholar]
  24. Riddell S. R., Watanabe K. S., Goodrich J. M., Li C. R., Agha M. E., Greenberg P. D. 1992; Restoration of viral immunity in immuno- deficient humans by the adoptive transfer of T cell clones. Science 25:238–241
    [Google Scholar]
  25. Salazar-Mather T. P., Orange S. J., Biron C. A. 1998; Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1α(MIP-1α)-dependent pathways. Journal of Experimental Medicine 187:1–14
    [Google Scholar]
  26. Steffens H. -P., Kurz S., Holtappels R., Reddehase M. J. 1998a; Preemptive CD8 T-cell immunotherapy of acute cytomegalovirus infection prevents lethal disease, limits the burden of latent viral genomes, andreduces therisk ofvirus recurrence. Journal of Virology 72:1797–1804
    [Google Scholar]
  27. Steffens H. -P., Podlech J., Kurz S., Angele P., Dreis D., Reddehase M. J. 1998b; Cytomegalovirus inhibits the engraftment of donor bone marrow cells by downregulation of hemopoietin gene expression in recipient stroma. Journal of Virology 72:5006–5015
    [Google Scholar]
  28. Walter E. A., Greenberg P. D., Gilbert M. J., Finch R. J., Watanabe K. S., Thomas E. D., Riddell S. R. 1995; Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. New England Journal of Medicine 333:1038–1044
    [Google Scholar]
  29. Winston D. J., Ho W. G., Champlin R. E. 1990; Cytomegalovirus infections after bone marrow transplantation. Reviews ofInfectious Diseases 12:S776–S792
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-79-9-2099
Loading
/content/journal/jgv/10.1099/0022-1317-79-9-2099
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error